• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Atherosclerosis . The prognostic role of cardiac troponin in hospitalized COVID-19 patients

tetano

Editor, Senior Moderator
Atherosclerosis


. 2021 Apr 17;325:83-88.
doi: 10.1016/j.atherosclerosis.2021.04.006. Online ahead of print.
The prognostic role of cardiac troponin in hospitalized COVID-19 patients


Ibrahim Halil Tanbo?a[SUP] 1 [/SUP], U?ur Canpolat[SUP] 2 [/SUP], Elif Hande ?zcan ?etin[SUP] 3 [/SUP], Harun Kundi[SUP] 3 [/SUP], Sema Turan[SUP] 4 [/SUP], Osman Celik[SUP] 5 [/SUP], Naim Ata[SUP] 5 [/SUP], Serkan ?ay[SUP] 6 [/SUP], ?zcan ?zeke[SUP] 6 [/SUP], Cihangir Kaymaz[SUP] 7 [/SUP], Serkan Topalo?lu[SUP] 6 [/SUP]



Affiliations
Free PMC article

Abstract

Background and aims: Myocardial injury defined by elevation of cardiac troponins (cTn) in the course of coronavirus disease 2019 (COVID-19) pandemic has been reported, though not fully characterized yet. Using the Turkish nationwide centralized COVID-19 database, we sought to determine whether cTn measured within 24 h of admission may help identify 30-day all-cause mortality in hospitalized patients.
Methods: This retrospective cohort study was conducted at all hospitals in Turkey between March 11, 2020, and June 22, 2020. All hospitalized COVID-19 patients (?18 years) who had cTn measurements within 24 h of admission were included. The primary outcome was 30-day all-cause mortality.
Results: A total of 14,855 COVID-19 patients (median age 49 years and 54% male) from 81 provinces of Turkey were included. Of these, 2020 patients (13.6%) were transferred to intensive care unit, 1165 patients (7.8%) needed mechanical ventilation, and 882 patients (5.9%) died during hospitalization. The prevalence of cTn positivity was 6.9% (n = 1027) in the hospitalized patients. cTn positivity was 5% in those patients alive at 30-day, and 44% in those who died. In multivariable Cox proportional hazard regression model, age, lactate dehydrogenase, and cTn were the strongest predictors of 30-day mortality, irrespective of cTn definition as a continuous, ordinal variable, or dichotomic variables.
Conclusions: A single measurement of cTn at admission in patients with COVID-19 is associated with 30-day all-cause mortality and may have an important prognostic role for optimizing risk stratification.

Keywords: COVID-19; Mortality; Prognosis; Troponin.
 
Back
Top Bottom